These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy. Sorosky JI; Ingardia CJ; Botti JJ Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318 [TBL] [Abstract][Full Text] [Related]
5. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction]. Schulte-Sasse U; Eberlein HJ Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426 [TBL] [Abstract][Full Text] [Related]
6. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient]. Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231 [No Abstract] [Full Text] [Related]
7. [New findings and experiences in the field of malignant hyperthermia]. Schulte-Sasse U; Eberlein HJ Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519 [TBL] [Abstract][Full Text] [Related]
8. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine. Harrison GG Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645 [TBL] [Abstract][Full Text] [Related]
9. General anesthesia in a malignant hyperthermia susceptible patient. Jones JE; Dierdorf SF; Clapp DW J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215 [No Abstract] [Full Text] [Related]
10. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia. López JR; Medina P; Alamo L Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441 [TBL] [Abstract][Full Text] [Related]
11. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. Free CW; Jaimon MP N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330 [TBL] [Abstract][Full Text] [Related]
12. Halothane induced porcine malignant hyperthermia reversed by dantrolene. Alitalo I; Schulman A Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129 [TBL] [Abstract][Full Text] [Related]
13. [Caesarean section in a patient with past history of fulminant malignant hyperthermia]. Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362 [TBL] [Abstract][Full Text] [Related]
14. Multiple-pulse stimulation and dantrolene in malignant hyperthermia. Quinlan JG; Wedel DJ; Iaizzo PA Muscle Nerve; 1990 Oct; 13(10):904-8. PubMed ID: 2233846 [TBL] [Abstract][Full Text] [Related]
16. Current understanding of malignant hyperthermia: genesis, prevention, and treatment. Katz DN CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145 [TBL] [Abstract][Full Text] [Related]
17. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)]. Bernhardt D Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034 [TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia: a potentially fatal complication of anesthesia. Stolworthy C; Haas RE Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843 [TBL] [Abstract][Full Text] [Related]
19. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients]. Mauritz W; Hackl W; Sporn P; Steinbereithner K Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878 [TBL] [Abstract][Full Text] [Related]